On assessing survival benefit of immunotherapy using long-term restricted mean survival time (Q6617469)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: On assessing survival benefit of immunotherapy using long-term restricted mean survival time |
scientific article; zbMATH DE number 7924995
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | On assessing survival benefit of immunotherapy using long-term restricted mean survival time |
scientific article; zbMATH DE number 7924995 |
Statements
On assessing survival benefit of immunotherapy using long-term restricted mean survival time (English)
0 references
11 October 2024
0 references
delayed difference
0 references
hazard ratio
0 references
non-proportional hazards
0 references
versatile test
0 references
weighted logrank test
0 references
0 references
0 references
